Even as drug shortages squeeze the pharmaceutical industry and weigh on patients, one of the world’s top generic manufacturers is planning to cut parts of its portfolio. At Teva’s recent investor day, ...

Here are four ways Dr. Gottlieb seeks to address high drug costs. 1. Increase generic competition. Dr. Gottlieb told Bloomberg the FDA is exploring how to prioritize the review of applications for ...

Between now and 2015, about $138 billion in drug sales across eight major developed markets will be at risk to generic competition, according to the market research firm IMS Health. As a result, ...

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and ...